Detalhe da pesquisa
1.
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.
Clin Infect Dis
; 62(11): 1329-1335, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001804
2.
An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression.
Rheumatology (Oxford)
; 52(5): 839-46, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23287359
3.
Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study.
Ann Rheum Dis
; 71(10): 1692-7, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22596166
4.
Update on CVD 103-HgR single-dose, live oral cholera vaccine.
Expert Rev Vaccines
; 21(1): 9-23, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775892
5.
Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis.
Crit Care Med
; 38(2): 539-45, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19851093
6.
Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
Vaccine
; 36(20): 2768-2773, 2018 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29655627
7.
Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
PLoS Negl Trop Dis
; 12(4): e0006376, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624592
8.
Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Naïve Population.
Clin Vaccine Immunol
; 2017 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566334
9.
The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
Clin Vaccine Immunol
; 24(1)2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27847368
10.
ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis.
Pediatr Crit Care Med
; 7(3): 200-11, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16575354
11.
Development of a multi-biomarker disease activity test for rheumatoid arthritis.
PLoS One
; 8(4): e60635, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585841
12.
Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis.
J Pharm Biomed Anal
; 70: 415-24, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22749821
13.
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.
Arthritis Care Res (Hoboken)
; 64(12): 1794-803, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22736476
14.
Severe protein C deficiency is associated with organ dysfunction in patients with severe sepsis.
J Crit Care
; 26(6): 539-45, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21737232
15.
Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.
Clin J Am Soc Nephrol
; 2(4): 631-6, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17699475
16.
Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors.
J Infect Dis
; 186(1): 15-22, 2002 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12089657
17.
Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
Diabetes Care
; 30(4): 995-6, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17229944